rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    COSM
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
      13h agoYahoo FinanceCOSM
      Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized

      Monthly subscription value of $1.83 million as of October 31, 2026, approximately $22.0 million on an annualized

      Nov 11USA TodayCOSM
      Cosmos Health to implement 1-for-20 reverse stock split effective Thursday
      Nov 10Investing.comCOSM
      Cosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
      Nov 5MorningstarCOSM
      Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks

      Active subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14,

      Oct 29USA TodayCOSM
      Noble Capital initiates Cosmos Health stock with outperform rating
      Oct 26Investing.comCOSM
      Cosmos Health expands e-commerce to Australia and New Zealand
      Oct 22Investing.comCOSM
      Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
      Oct 22Yahoo FinanceCOSM
      Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
      Oct 20Yahoo FinanceCOSM
      Cosmos Health projects $15M Q4 U.S. revenue, 70% margin
      Oct 19Investing.comCOSM
      Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days

      revenue: approximately $15 million expected, based on the Company's current growth trajectory● Q4 2026 gross profit: approximately $10.5 million expected, at an approximately 70% gross margin● Subscription revenue: approximately $11.

      Oct 19Yahoo FinanceCOSM
      Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription

      ● 6,287 active U.S. subscriptions as of October 14, 2026, the vast majority added since mid-September as the Company

      Oct 14USA TodayCOSM
      Cosmos Health reports 6,287 active U.S. subscriptions
      Oct 14Investing.comCOSM
      COSM US Growth Impresses
      Oct 14Yahoo FinanceCOSM
      Cosmos Health reports record daily U.S. sales of $92,000
      Oct 13Investing.comCOSM
      Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days
      Oct 13Yahoo FinanceCOSM
      Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
      Oct 7MorningstarCOSM
      COSM Continues to Surge Revenue Growth
      Oct 7Yahoo FinanceCOSM
      Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
      Oct 1MorningstarCOSM
      COSM Continues to Grow Business
      Sep 29Yahoo FinanceCOSM
      Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue
      Sep 29Investing.comCOSM
      Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
      Sep 29MorningstarCOSM
      Cosmos Health’s Cana unit surpasses $20M CMO pipeline
      Sep 28Investing.comCOSM
      Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

      * Contract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in implied gross profit across the life of agreements * Gross margins of over 90% \- among the highest-margin revenue streams in the Company, with raw materials largely supplied by clients * Record production pipeline of more than 32.7 million units, up approximately sixfold since mid-2024 and close to threefold since the start of this year, with

      Sep 28Yahoo FinanceCOSM
      Cosmos Health subsidiary secures 5.2M unit manufacturing deal
      Sep 15Investing.comCOSM
      Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June

      7 million contracted units added in under two weeks \- Cana Laboratories' orderbook has grown from over 12 million units earlier this year to more than 32.7 million today * Secured orders for 1.

      Sep 15Yahoo FinanceCOSM
      Cosmos Health engages Prime Ledger for tokenized IP financing
      Sep 14Investing.comCOSM
      Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

      * Prime Ledger engaged to structure an asset-specific, non-dilutive tokenized financing for CCX0722 - backed by intellectual property, with no issuance of Cosmos Health common stock * Positions Cosmos Health among the earliest NASDAQ-listed healthcare companies pursuing tokenized IP-backed assets. * CCX0722 is an ingestible, hydrogel-based medical device in development for weight management, using a mechanical mechanism with no systemic absorption * Intellectual property owned outright, with pat

      Sep 14Yahoo FinanceCOSM
      Cosmos Health subsidiary secures 5-year manufacturing deal
      Sep 11Investing.comCOSM
      Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units

      * 500,000 contracted units of ROSARTIA annually / 2.5 million over five years through a new long-term agreement at wholly owned subsidiary Cana Laboratories * Expands Cosmos Health's manufacturing presence in cardiovascular pharmaceuticals, adding production of statin-based lipid-lowering therapies to Cana's growing contract manufacturing portfolio * Cumulative contract manufacturing orderbook increases to more than 27.

      Sep 11Yahoo FinanceCOSM
      Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine

      Cosmos Health (COSM) said Friday its unit Cana Laboratories entered a new five-year contract manufac

      Sep 11Yahoo FinanceCOSM
      Cosmos Health receives first orders for veterinary product line
      Sep 9Investing.comCOSM
      Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market

      2 million in adjusted EBITDA and $31 million in net incomeCHICAGO, IL / ACCESS Newswire / September 9, 2026 / ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has received its first orders for its veterinary antimicrobial line, which will be marketed under the brand name C-ScrubVet.C-ScrubVet Wash 4% CHDG is a veterinary antimicrobial cleanser containing 4% chlorhexidine digluconate, effective against bacteria

      Sep 9Yahoo FinanceCOSM
      Cosmos Health reports record revenue, retires $8M debt early
      Sep 3Investing.comCOSM
      Cosmos Health: A Company Transformed — 2026 Year-to-Date

      A Comprehensive Corporate Summary — January 1, 2026 through August 31, 2026 Revenue record set three consecutive quarters: FY2025 $65.3M (+20%) →...

      Sep 3Business InsiderCOSM
      Cosmos Health retires $8M convertible note early
      Aug 28Investing.comCOSM
      Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions

      Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions

      Aug 28BarchartCOSM
      Cosmos Health projects $6M revenue from Oliv18 supplement launch
      Aug 24Investing.comCOSM
      Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories

      Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories

      Aug 24BarchartCOSM

      This is the newest page. Registered accounts read further back.